Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKI Kimio Yonesaka, Kaoru Tanaka, Mutsukazu Kitano, Hisato Kawakami, Hidetoshi Hayashi et al. Oncogenesis 2019 8: 10.1038/s41389-019-0164-9 Abstract | Full Text

UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis Mohsen Hosseini, Léa Dousset, Pauline Michon, Walid Mahfouf, Elodie Muzotte et al. Oncogenesis 2019 8: 10.1038/s41389-019-0161-z Abstract | Full Text

PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner Dehong Luo, Daishun Liu, Wen Shi, Huimin Jiang, Wei Liu et al. Oncogenesis 2019 8: 10.1038/s41389-019-0162-y Abstract | Full Text

Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer Ying Yang, Ziming Li, Hong Yuan, Wenxiang Ji, Kaixuan Wang et al. Oncogenesis 2019 8: 10.1038/s41389-019-0151-1 Abstract | Full Text

EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma Yi-Hung Carol Tan, Saumya Srivastava, Brian M. Won, Rajani Kanteti, Qudsia Arif et al. Oncogenesis 2019 8: 10.1038/s41389-019-0159-6 Abstract | Full Text

NCAM1/FGF module serves as a putative pleuropulmonary blastoma therapeutic target Rachel Shukrun, Hana Golan, Revital Caspi, Naomi Pode-Shakked, Oren Pleniceanu et al. Oncogenesis 2019 8: 10.1038/s41389-019-0156-9 Abstract | Full Text